Brief: Replicel Life Sciences Says Replicel Announces A Letter Of Intent For Asset Purchase Agreement
18/03/2024 17:59
March 18 (Reuters) - Replicel Life Sciences Inc RP.V :
* REPLICEL LIFE SCIENCES INC - REPLICEL ANNOUNCES A LETTER
OF
INTENT FOR ASSET PURCHASE AGREEMENT
* REPLICEL LIFE SCIENCES-LOI SAYS ASSETS TO BE BOUGHT FROM
CO IN
EXCHANGE FOR 8% ROYALTY ON GROSS PROFITS EARNED BY 1456390 B.C.
RELATED TO ASSET SALE
Source text for Eikon: ID:
Further company coverage: RP.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Replicel Life Sciences
See all newsBrief: Replicel Life Sciences Announces Reinstatement Of Trading & Conditional Acceptance For Proposed Transaction
Brief: Replicel Life Sciences Says Replicel Announces A Letter Of Intent For Asset Purchase Agreement
Brief: Replicel Announces Binding Term Sheet For Strategic Investment And U.S. Partnership
Brief: Replicel Announces Its Incoming Board Of Directors
Brief: RepliCel Life Sciences Retains Dermatology Sales And Marketing Executive To Guide Global Commercial Strategy For Automated Dermal Injector